Jing Zhu

Company: RVAC Medicines

Job title: Director, Process & Analytical Development

Seminars:

Case Study 4: Examining New Identity (ID) Assays for Multivalent mRNA Vaccines 3:15 pm

Identity (ID) assay required as both in-process and final releasing assays for mRNA vaccines Current progress and challenges of sequence methods as orthogonal approaches for multivalent mRNA ID assay Two newly developed ID methods demonstrated their advantages including shortened lead time, flexibility as a platform method and low requirement for in-house lab capacityRead more

day: Focus Day